Macular degeneration
Researchers at the Second Affiliated Hospital of Xi'an Medical University in China have discovered a significant association between age-related macular degeneration (AMD) and seasonal affective disorder (SAD). The study, published in Actas Espanolas de Psiquiatria, aimed to explore the influence of AMD on SAD and assess the correlation
Macular degeneration
Researchers at the Second Affiliated Hospital of Xi'an Medical University in China have discovered a significant association between age-related macular degeneration (AMD) and seasonal affective disorder (SAD). The study, published in Actas Espanolas de Psiquiatria, aimed to explore the influence of AMD on SAD and assess the correlation
Charles University
Research findings have been presented on the efficacy and safety of switching from ranibizumab to brolucizumab in the treatment of wet age-related macular degeneration (wAMD). A multicenter retrospective study included patients aged 50 years with active wAMD, and the results showed that switching to brolucizumab reduced central retinal thickness (CRT)
Eye diseases
A team of international experts has collaborated to establish a standardized set of outcome measures for patients affected by non-advanced age-related macular degeneration (AMD). This consensus statement, published in the British Journal of Ophthalmology, aims to facilitate global data collection and longitudinal research on the condition. The study employed a
Eye diseases
A new study has shed light on the disparities in presentation and initiation of anti-VEGF therapy among patients with neovascular age-related macular degeneration (nAMD). Researchers from Thomas Jefferson University analyzed data from the American Academy of Ophthalmology IRIS Registry, revealing that male, Black, and Hispanic patients with nAMD presented at
Macular degeneration
Researchers from Sichuan University have made a groundbreaking discovery in the field of age-related macular degeneration (AMD), a leading cause of visual impairment in the aging population. According to the study published in Survey of Ophthalmology, cellular senescence in retinal pigment epithelium (RPE) plays a pivotal role in the pathogenesis
Eye diseases
A team of international experts has collaborated to establish a standardized set of outcome measures for patients affected by non-advanced age-related macular degeneration (AMD). This consensus statement, published in the British Journal of Ophthalmology, aims to facilitate global data collection and longitudinal research on the condition. The study employed a
Eye diseases
A team of international experts has collaborated to establish a standardized set of outcome measures for patients affected by non-advanced age-related macular degeneration (AMD). This consensus statement, published in the British Journal of Ophthalmology, aims to facilitate global data collection and longitudinal research on the condition. The study employed a
Blindness
Medical researchers have announced a breakthrough in the treatment of advanced dry age-related macular degeneration (AMD), a leading cause of blindness worldwide. A tiny electronic implant paired with special glasses has enabled 27 (84 per cent) of 32 patients to regain functional vision, including the ability to read letters, numbers,
Blindness
Medical researchers have announced a breakthrough in the treatment of advanced dry age-related macular degeneration (AMD), a leading cause of blindness worldwide. A tiny electronic implant paired with special glasses has enabled 27 (84 per cent) of 32 patients to regain functional vision, including the ability to read letters, numbers,
Macular degeneration
A groundbreaking clinical trial has resulted in the publication of a peer-reviewed original paper in the New England Journal of Medicine, showcasing the effectiveness of Science Corporation's PRIMA brain-computer interface (BCI) retinal implant. The study demonstrated that PRIMA restored functional central vision to patients suffering from geographic atrophy
Blindness
A groundbreaking clinical trial has resulted in the publication of a peer-reviewed original paper in the New England Journal of Medicine, showcasing the effectiveness of Science Corporation's PRIMA brain-computer interface (BCI) retinal implant. The study demonstrated that PRIMA restored functional central vision to patients suffering from geographic atrophy
